Join
Live feed
·
INSIDERFilingvia Quantisnow
Zymeworks Inc. logo

EVP & Chief Medical Officer Smith Jeffrey T L converted options into 20,000 shares and sold $165,807 worth of shares (11,110 units at $14.92) (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
ZYME· Zymeworks Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ZYME (Zymeworks Inc.) and more on Quantisnow.